Woman of the Week: Genentech's Quita Highsmith

Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.

By Taren Grom • March 9, 2022

Horizon’s VP of R&D on her ascent in biotech — and bringing other female scientists along for the ride

Elizabeth Thompson is guiding Horizon through new drug approvals while leading the way for young women in STEM.

By Alexandra Pecci • March 8, 2022

Explore the Trendline➔

Commercialization, marketing and social media

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

By PharmaVoice staff

Ramona Sequeira breaks PhRMA's glass ceiling

A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.

By Taren Grom • March 7, 2022

Woman of the Week: Lyndra Therapeutics' CEO Dr. Trish Hurter

With Lyndra's ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.

By Taren Grom • March 2, 2022

The 2022 PharmaVoice 100 — new look, same drive for excellence

Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.  

By Taren Grom • Feb. 28, 2022

Candel's CEO looks to help ignite a new era of cancer treatments

Candel Therapeutics is advancing a next-gen approach in oncology: using viruses to kill cancer cells at the site of injection.

By Taren Grom • Feb. 28, 2022

Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo

Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.

By Taren Grom • Feb. 23, 2022

Woman of the Week: Organon's Chief Commercial Officer Susanne Fiedler

Susi Fiedler, chief commercial officer, was instrumental in the spinout of Organon as a standalone company focused on a broad range of women’s health issues.

By Taren Grom • Feb. 16, 2022

New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality

Read what Capsida CEO Peter Anastasiou has planned for his new role. 

By Taren Grom • Feb. 3, 2022

Woman of the Week: Google Cloud's Andrea McGonigle

Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.

By Taren Grom • Feb. 2, 2022

Woman of the Week: Syneos Health's president of commercial solutions, Michelle Keefe

How Michelle Keefe, president, commercial solutions at Syneos Health, steered her team into a rapid pivot during the pandemic.

By Taren Grom • Feb. 2, 2022

Talent acquisition stays top of mind for pharma execs

From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

By Taren Grom • Feb. 1, 2022

Biopharma's R&D leaders on how technology can accelerate drug development

How emerging digital tools are providing enhanced clinical insights and improved trial results.

By Taren Grom • Jan. 27, 2022

One man's quest to boost the patient's role in clinical trials

How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.

By Robin Robinson • Jan. 24, 2022

Leaders predict improving patient engagement will lead to growth opportunities

Why patient engagement is key to successful business growth.

By Taren Grom • Jan. 24, 2022

Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

By Alexandra Pecci • Jan. 23, 2022

Woman of the Week: Pfizer CMO Dr. Aida Habtezion

Pfizer's CMO shares her experiences transforming the company's R&D culture and improving health equity

By Taren Grom • Jan. 19, 2022

Pharma execs reveal the industry's most pressing issues

Several market factors — including COVID — are driving changes and trends in the industry.

By Taren Grom • Jan. 14, 2022

Welcome to the new PharmaVoice

A similar mission, a new format, and our plans for PharmaVoice's next chapter.

By Davide Savenije • Jan. 13, 2022

Ovid's CEO shares his vision for rare disease developments

Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

By Kim Ribbink • Jan. 10, 2022

Shifting the Conversation on Diversity and Inclusion

COVID-19 and the Black Lives Matter movement have prompted many companies to step up diversity and inclusion initiatives. The past 18 months, with the global pandemic and social unrest following the deaths of George Floyd and Breonna Taylor, have shone an even brighter light on diversity and incl...

By Kim Ribbink • Oct. 1, 2021

Letter from the Editor

Who you gonna call? Alexa, Echo, Siri, et al … voice assistants to the rescue? Or not? Let’s face it, we all engage our smart tools to do everything from changing the channel to ordering groceries to finding out which team won the ballgame to setting the temperature and lights. The time has now c...

By Taren Grom • Sept. 1, 2021

Healthcare Has Much to Teach Big Tech About Human Relationships

In July, an artificial intelligence subsidiary of Alphabet, Google’s parent, provided the latest glimpse of how Big Tech is changing life sciences. An AI tool called AlphaFold, from Alphabet’s Deep Mind unit, predicted the 3D structure of nearly all human proteins and put the information in a pub...

By Michelle Keefe • Sept. 1, 2021

PharmaVoice 100 Who's on the List – By Category

Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

By PharmaVoice Team • Aug. 1, 2021

Entrepreneurs

These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights. Do you have CLAS? (Culturally and Linguistically Appropriate Strategies) Igniting change by… Having courageous conversations about race, ethnicity...

By PharmaVoice Team • Aug. 1, 2021